WebMar 31, 2024 · CAREPLS +4.41% Join for free to get the full story Keep reading Love in every #TradingView 50M+ Traders and investors use our platform #1 Top website in the world when it comes to all things investing 4.9 From 1M+ reviews. No other finance app is more loved 10M+ Custom scripts and ideas shared by our users @tradingview @fx_papi … WebCAREPLS fundamentals. Overview Statements Statistics Dividends Earnings Revenue More. CAREPLUS GROUP BERHAD key financial stats and ratios. If you want to check out CAREPLS market capitalization, P/E Ratio, EPS, ROI, and other financial ratios, this page is your go-to hub. Statistics. Annual Quarterly More. Q2 '21. Q3 '21. Q4 '21. Q1 '22.
CAREPLS - CAREPLUS GROUP BERHAD (0163.MY)
WebApr 6, 2024 · Careplus to Grant 5.5 Million Shares to Eligible Employees, Directors Apr 5, 202420:30 PDT CAREPLS Join for free to get the full story Keep reading Love in every #TradingView 50M+ Traders and investors use our platform #1 Top website in the world when it comes to all things investing 4.9 From 1M+ reviews. No other finance app is … WebApr 10, 2024 · CAREPLS Stock Overview. Careplus Group Berhad, an investment … hoho after this rain2017
[CAREPLS] Change In Director
WebApr 12, 2024 · CAREPLUS GROUP BERHAD Particulars of substantial Securities Holder Details of changes Remarks : 1. Direct interest of 93,964,200 shares are held through:- a. Lim Kwee Shyan - 35,914,300 shares b. WebApr 11, 2024 · CAREPLS: Additional Listing Detail: [CAREPLS] Others on 11-Apr-2024. Welcome! Select a username of your choice. Username . 6 to 20 characters, no spaces or special characters ... Allotment of Shares pursuant to the Company's Share Grant Plan. No. of shared issued. 3,492,800. Issue Price. MYR 0.150. Par Value. 0.000. Total NOSH. … WebApr 10, 2024 · CAREPLS Stock Overview Careplus Group Berhad, an investment holding company, engages in the manufacture and processing of gloves in South America, North America, the Asia Pacific, Malaysia, and internationally. About the company Rewards Trading at 39.9% below our estimate of its fair value Risk Analysis hohn vs hickman cath